共 40 条
[21]
Masugata H., Senda S., Goda F., Et al., Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome, Hypertens Res, 29, pp. 897-903, (2006)
[22]
Boudina S., Abel E.D., Diabetic cardiomyopathy revisited, Circulation, 115, pp. 3213-3223, (2007)
[23]
Al Zadjali M.A., Godfrey V., Khan F., Et al., Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure, J Am Coll Cardiol, 53, pp. 747-753, (2009)
[24]
Doehner W., Rauchhaus M., Ponikowski P., Et al., Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure, J Am Coll Cardiol, 46, pp. 1019-1026, (2005)
[25]
Ingelsson E., Arnlov J., Lind L., Sundstrom J., Metabolic syndrome and risk for heart failure in middle-aged men, Heart, 92, pp. 1409-1413, (2006)
[26]
Witteles R.M., Fowler M.B., Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options, J Am Coll Cardiol, 51, pp. 93-102, (2008)
[27]
UK Prospective Diabetes Study (UKPDS) Group, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34, Lancet, 352, pp. 854-865, (1998)
[28]
Bethel M.A., Califf R.M., Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease, Am J Cardiol, 99, pp. 726-731, (2007)
[29]
Dasgupta K., Grover S.A., Da Costa D., Lowensteyn I., Yale J.F., Rahme E., Impact of modified glucose target and exercise interventions on vascular risk factors, Diabetes Res Clin Pract, 72, pp. 53-60, (2006)
[30]
Cittadini A., Napoli R., Monti M.G., Et al., Metformin prevents the development of chronic heart failure in the SHHF rat model, Diabetes, 61, pp. 944-953, (2012)